Key statistics
On Friday, VolitionRX Ltd (VNRX:ASQ) closed at 0.6677, -28.97% below its 52-week high of 0.94, set on Jun 23, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.6684 |
---|---|
High | 0.675 |
Low | 0.65 |
Bid | 0.6403 |
Offer | 0.6789 |
Previous close | 0.68 |
Average volume | 152.67k |
---|---|
Shares outstanding | 103.02m |
Free float | 71.52m |
P/E (TTM) | -- |
Market cap | 70.06m USD |
EPS (TTM) | -0.2688 USD |
Data delayed at least 15 minutes, as of Jul 11 2025 20:59 BST.
More ▼
- Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes
- Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure
- Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties
- VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats
- VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update
- VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update
- VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q® NETs test adoption
- VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets
More ▼